Cardiovascular dysfunction and remodeling have been found in some children conceived by in vitro fertilization (IVF). However, the underlying mechanisms remain unclear. In this study, the retrospective investigation showed that the blood pressure of IVF-conceived Chinese children was higher than that of naturally conceived (NC) children at ages 3-13 yr. We analyzed the expression profile of proteins in the umbilical veins of IVF and NC newborns by proteomic techniques. Using iTRAQ (isobaric tags for relative and absolute quantitation), 47 differentially expressed proteins (DEPs) were identified by feature selection in IVF umbilical veins compared with NC. Ingenuity Pathway Analysis, which is used to explore the signaling pathways of DEPs, revealed that these DEPs played important roles in vascular system development and carbon metabolism, implying that these DEPs might be potential candidates for further exploration of the mechanism(s) of vascular dysfunction in IVF children. We found that the serum estradiol (E 2 ) level in the cord blood of IVF newborns was significantly higher than that of NC newborns. High concentrations of E 2 induced alteration of lumican and vimentin expression in human umbilical vein endothelial cells, which was consistent with the proteomic results. These findings suggested that abnormal expression of proteins in umbilical veins might be related to the cardiovascular dysfunction and remodeling in IVF offspring. In conclusion, our data for the first time reveal the protein expression profile in blood vessels of IVF offspring and provide information for further mechanism study and evaluation of risks of cardiovascular abnormality in IVF children.
INTRODUCTION
Since the birth of the first baby conceived using in vitro fertilization (IVF), in 1978, the number of IVF-conceived children is increasing rapidly. Although the majority of IVFconceived children are healthy, the potentially negative effects of assisted reproductive technology (ART) on IVF-conceived children are concerning [1] . Increased risks of birth defects [2] [3] [4] [5] , epigenetic disorders [6] [7] [8] , and adverse pregnancy outcomes, such as low birth weight [9] , lower gestational age [10] , and multiple births [8] , have been found with pregnancies involving ART.
Existing data also have revealed that some IVF-conceived children show vascular dysfunction [11] and cardiovascular remolding [12] . Epidemiological investigations demonstrated that the blood pressure of IVF-born children was higher than that of spontaneously born children [13, 14] . In line with this speculation, studies in normal mice showed that ART might cause vascular dysfunction and arterial hypertension in offspring [15, 16] . However, little is known about the mechanisms underlying the vascular dysfunction of IVF-born children. According to the theory of ''gamete and embryo-fetal origins of adult diseases'' [17] , adverse environmental stimuli during critical or sensitive periods in early life could lead to adverse alterations of endocrine function and metabolism that will predispose the individual to cardiovascular diseases in later life [18] [19] [20] . To clarify the causes and mechanisms of vascular dysfunctions in IVF offspring, in-depth investigations are required.
Proteins are the executors of physiological functions. Our previous study demonstrated that ART might induce the alteration of protein expression profile in the IVF placenta, suggesting that the differentially expressed proteins (DEPs) may be valuable for the evaluation of a potential association between ART treatment and adverse outcomes of offspring [21] . However, to date no reports have been done on screening some particular unraveled molecular complexes or pathways in the pathogenesis of the human vascular system following IVF treatment by proteomic analysis. iTRAQ is the latest proteomic technology, with high repeatability, accuracy, and precision [22] . So, taking advantage of iTRAQ, we detected the protein expression profiles in umbilical veins from IVF and naturally conceived (NC) newborns. The proteomic results, combined with the following study of estradiol (E 2 ) in cord blood and in human umbilical vein endothelial cells (HUVECs), will contribute to an understanding of the mechanisms of vascular dysfunction in IVF-born children.
MATERIALS AND METHODS

Study Population
The study protocol was approved by the Research and Ethics Committee of the Women's Hospital, School of Medicine, Zhejiang University, China. Informed consent was provided by all participants. Follow-up study in children conceived by IVF ages 3-13 yr was performed in the Reproductive Center of the Women's Hospital. We recruited 704 singletons born by IVF and fresh embryo transfer (IVF-ET) during 1999-2009. Physical examination, including height, body weight, body mass index (BMI), blood pressure, and heart rate, was performed. By contrast, 704 singletons conceived spontaneously and born in the same period served as controls. Children were excluded if they were born with cardiovascular diseases or congenital anomalies, were born preterm or small for gestational age, or were born of a postterm pregnancy; they were also excluded if their mothers experienced preeclampsia and gestational diabetes during pregnancy.
Tissue Samples
Umbilical vessels and cord blood from 45 IVF and 48 NC newborns were collected after cesarean delivery in the Women's Hospital. The detailed characteristics of these samples are listed in Supplemental Table S1 (Supplemental Data are available online at www.biolreprod.org). Mothers of IVF babies had normal ovarian function and underwent controlled ovarian hyperstimulation with gonadotropins followed by the standard luteal long gonadotropin-releasing hormone agonist down-regulation protocol for the first IVF cycle. Human chorionic gonadotropin was administered when three or more follicles were 17 mm in diameter, and transvaginal ultrasound-guided oocyte retrieval was performed in 34-36 h. Embryo transfer was performed after 2-3 days of IVF. All babies included met the following criteria: maternal age between 25 and 35 yr; full-term delivery; singleton pregnancy; child birth weight between 2500 and 4000 g; no indication of pregnancy complications; no birth defects; and no cardiovascular diseases. We examined the E 2 levels in cord blood from newborns and used a unified and randomized program created by computer to select three umbilical veins from the IVF group and three umbilical veins from the NC group. These six samples were used for proteomic analysis. For validation, 11 umbilical veins from each group were used for realtime PCR analysis, and 4 umbilical veins from each group were used for Western blot analysis.
Sample Preparation
Approximately 100 mg of frozen umbilical veins was ground into a powder in liquid nitrogen and homogenized in extraction buffer (4% SDS, 1 mM dithiothreitol, and 150 mM Tris-HCl [pH 8]). Protein extraction was performed with cell lysis at 958C for 5 min, followed by sonication on ice. The crude extracts were incubated at 958C and cleared by centrifugation at 14 000 3 g for 30 min at 158C. Thereafter, the supernatant was collected and protein concentration was measured by the BCA protein assay reagent (Pierce).
Protein Digestion and iTRAQ Labeling
Protein digestion was performed according to the FASP procedure described by Wisniewski et al. [23] . Resulting peptides were estimated by ultraviolet light spectral density at OD 280 [24] . The resulting peptide mixture was labeled using the 8-plex iTRAQ reagent according to the manufacturer's instructions (AB Sciex). Three umbilical veins from NC babies (C) were labeled with mass 114, 115, and 116 isobaric iTRAQ tags, whereas three umbilical veins from IVF babies (T) were labeled with mass 117, 118, and 119 isobaric iTRAQ tags. Identical-quality peptide mixture of all six samples was labeled with reagent 113 and served as a sample reference. We performed three independent biological experiments. Before further analysis, the labeling solution reaction was incubated at room temperature for 2 h.
Strong Cationic-Exchange Chromatography Separation
The combined sample was acidified with 1% trifluoroacetic acid before being subjected to strong cationic-exchange chromatography (SCX) fractionation using a Poly SULFOETHYL column (4.6 3 100 mm, 5 lm, 200 Å ; Poly LC Inc.). Solvent A was 10 mM KH 2 PO 4 in 25% (v/v) acetonitrile, and solvent B was solvent A with 500 mM KCl. The solvents were applied using a gradient of 0%-10% solvent B for 2 min, 10%-20% solvent B for 25 min, 20%-45% solvent B for 5 min, and 50%-100% solvent B for 5 min. The elution was monitored by absorbance at 214 nm, and fractions were collected every 1 min. These samples were finally combined into 10 fractions, and then desalted on C18 cartridges (Sigma). Each SCX salt step fraction was dried in a vacuum centrifuge and reconstituted with 40 ll of 0.1% (v/v) trifluoroacetic acid.
Liquid Chromatography-Electrospray Ionisation (ESI)-Tandem Mass Spectrometry Analysis
The SCX fractions were thawed and dissolved in solvent C (0.1% [v/v] formic acid in Milli-Q water [Millipore] ). The peptide mixture (5 lg) of each fraction was subjected to nano liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis, and then was separated using the Thermo EASYnLC column (100 mm 3 75 lm, 3 lm; Thermo Scientific) with a linear gradient of solvent D (80% acetonitrile with 0.1% [v/v] formic acid) at a flow rate of 300 nl/min during 120 min: 0-100 min with 0%-45% solvent D; 100-108 min with 45%-100% solvent D; and 108-120 min with 100% solvent D.
The Q-Exactive (Thermo Scientific) mass spectrometer was used for data acquisition in the positive ion mode, with a selected mass range of 300-1800 mass/charge (m/z). Dynamic exclusion was used with 40-sec duration. QExactive survey scans were set as 70 000 at m/z 200 and 17 500 at m/z 200 of resolution for the high-energy collision-induced dissociation spectra. The MS/ MS data were acquired using data-dependent top 10 most abundant precursor ions. Normalized collision energy was 30 eV and underfill ratio was defined as 0.1% on the Q-Exactive.
Protein Identification and Quantification
Protein identification was performed using the MASCOT search engine (version 2.2.1; Matrix Science) and the Proteomics Tools (version 3.0.5; http:// www.proteomics.ac.cn/) [24] . Mascot generic format files were extracted from RAW files using Proteomics Tools against a uniport database of human protein sequences (03-2013, 133549 entries, downloaded from: http://www.uniprot. org/) using the MASCOT search engine. Search parameters were set as follows: monoisotopic mass, peptide mass tolerance at 620 ppm, and fragment mass tolerance at 0.1 Da; peptide charges were set to 2þ, 3þ, and 4þ, with trypsin used as the enzyme and allowing up to two missed cleavages. Variable modifications were defined as oxidation of methionine and iTRAQ 8-plexlabeled tyrosine, whereas lysine and the N-terminus of peptides labeled by iTRAQ 8-plex and carbamidomethylation on cysteine were specified as fixed modifications. The decoy database pattern was set as the reversed version of the target database.
The MASCOT search results were further processed using the Proteomics Tools (version 3.0.5), which includes such programs as Build Summary, Isobaric Labeling Multiple File Distiller, and Identified Protein iTRAQ Statistic Builder. The Build Summary program was used for assembling protein identifications based on a target-decoy search in shotgun proteomics. Falsediscovery rate of both protein and peptide identification was set to be less than 1% of 2*N (decoy)/[(N (decoy)þN (target)] [24] .
Isobaric Labeling Multiple File Distiller was used to calculate the relative ratios of identified peptides among labeled samples using relative peak intensities of released iTRAQ reporter ions in each of the MS/MS spectra. The Identified Protein iTRAQ Statistic Builder was used for assembling relative protein ratio among samples, which was based on weighted average of ratios of its unique peptides. The final ratio of the protein quantification from each sample was then normalized by the median ratio of the sample to the reference sample. This correction is based on the assumption that the expression of most proteins does not differ. Thus, if samples from each experimental condition are not combined in exactly equal amounts, this normalization will fix the systematic error. Only protein identification that was inferred from the unique peptide identification in all three independent experiments will be considered.
Quantitative Real-Time PCR Analysis
Total RNA was extracted from the samples using the Trizol reagents and reverse transcription method according to the manufacturer's instructions. Quantitative real-time PCR (Q-PCR) was carried out in Applied Biosystems 7900HT Fast (ABI). GAPDH served as an internal control. The primer sequences used in this study are listed in Supplemental Table S2 . Data were analyzed by the comparative threshold cycle (CT) method.
Western Blot Analysis
Protein samples of umbilical veins were prepared from IVF and NC groups, respectively. A total of 30 lg of protein was subjected to 10% SDS-PAGE and then transferred to nitrocellulose filter membrane (Bio-Rad). Nonspecific binding sites were blocked by 5% (v/v) nonfat milk in 13 PBS, at room temperature for 1 h. The membranes were then blotted with anti-lumican (1:500; ab70191; Abcam), anti-prostaglandin H2 D-isomerase (PTGDS; 1:200; GAO ET AL.
sc-30067; Santa Cruz Biotechnology), anti-nestin (1:200; sc-23927; Santa Cruz Biotechnology), anti-vimentin (1:1000; no. 5741; Cell Signaling Technology), or anti-b-actin (1:1000; no. F2119; Santa Cruz Biotechnology) at 48C overnight. After three washes with 13 PBST (PBS with 0.1% TWEEN 20), each membrane was incubated with the appropriate secondary antibody (1:5000) at room temperature for 1 h. After an additional three washes, protein intensities were determined and analyzed using an Odyssey Imager (LI-COR).
Feature Selection, Functional Analysis, and Network Generation of the DEPs
Feature selection is a process of selecting a subset of molecules that can best distinguish the samples by neglecting redundant or irrelevant features that provide little or no information in any context. Feature selection techniques are extremely useful in domains where there are many features and comparatively few samples. In this work, the information gain attribute evaluator (InfoGain) and correlation-based feature selection (CFS) from the WEKA machine learning package [25] were employed for the protein selection from the MS intensity values of C and T samples. The selected proteins were further inspected to retain the ones with a differential expression ratio of over 61.2. Using an Ingenuity Pathway Analysis (IPA) software package (Qiagen), functional analysis and network generation of the resulting DEPs were performed.
Cell Culture
The HUVECs were purchased from ScienCell and cultured in the endothelial cell medium (ScienCell). The cultures were supplemented with 5% fetal bovine serum and endothelial cell growth supplement (ScienCell). The HUVECs were used between passages 3 and 6.
Statistical Analysis
One-way ANOVA was used to analyze the results of the iTRAQ and Q-PCR analyses of HUVECs. Fisher exact test was used in functional analysis and network generation. Student t-test was used to determine the difference between two groups. Chi-square test was used to determine the difference between sexes. Differences were considered significant at P , 0.05.
RESULTS
Retrospective Investigation
Follow-up characteristics of the study population are shown in Supplemental Table S3 . The results of the follow-up study showed that the systolic and diastolic blood pressures were higher in IVF children than those in NC children at 3 yr , age 6 yr (preschool age) and 6 yr , age 13 yr (school age). However, the parameters including the height, weight, BMI, and sex did not show significant differences between two groups.
Protein Expression Profiles in Umbilical Veins from the IVF and NC Newborns
Three umbilical veins were sampled from the IVF and NC newborns, respectively. According to the UniProtKB database (Release 2013_10) in FASTA format, 723 proteins in umbilical veins were identified in the IVF group, including 335 upregulated proteins and 388 down-regulated proteins (Fig. 1A) . The CFS was employed for the protein selection from the MS intensity values of T (IVF) and C (NC) samples. Compared with the NC group, 47 DEPs in umbilical veins of IVF newborns were identified (Table 1) . Among these 47 DEPs, 20 proteins were up-regulated, whereas 27 proteins were downregulated (Fig. 1A) . The capability of the resulting feature proteins in differentiating two groups of samples was then evaluated by hierarchical clustering analysis (Fig. 1B) . Results showed a striking separation of the two groups into two major opposing branches, indicating that the proteins expressed in umbilical veins of IVF newborns were distinct from those of the NC newborns.
Validation of Two DEPs with Q-PCR and Western Blotting
To confirm the proteomic results, three up-regulated proteins-lumican, nestin, and PTGDS-and one downregulated protein-vimentin-in umbilical veins from IVF and NC groups were identified with Q-PCR ( Fig. 2A) and Western blot (Fig. 2B) analyses. The results of Q-PCR and Western blotting showed that in the IVF group, the expression levels of lumican, nestin, and PTGDS were up-regulated and the expression level of vimentin was down-regulated. These results were in line with those of proteomic analysis, indicating good iTRAQ quantification accuracy and good precision were achieved when applying our settings.
Ingenuity Pathway Analysis of the DEPs
To better understand the potential function of 47 DEPs, IPA software was used for further analysis. Based on 47 DEPs, the functional analysis showed that these DEPs could be grouped into three categories: ''disease and disorder'' (Fig. 3A) , ''molecular and cell functions'' (Fig. 3B) , and ''physiological system development and functions'' (Fig. 3C ). In the category of physiological system development and functions, the top three systems included tumor morphology, hair and skin development and function, and cardiovascular system development and function. In the potential network analysis, two networks were enriched with the highest score of 34. One significantly disturbed network was ''developmental disorder, hematological disease, hereditary disorder'' (Fig. 4A) . Another network was ''carbohydrate metabolism, small molecule biochemistry, cardiac arrhythmia'' (Fig. 4B) . We also found two other networks, including ''cell-to-cell signaling and interaction, cellular compromise, cardiovascular disease'' and ''drug metabolism, auditory disease, small molecule biochemistry,'' with scores of 18 and 13, respectively (Supplemental Table S4 ). The bioinformatics analysis revealed that these DEPs from umbilical veins were related to cardiovascular system development and carbon metabolism. However, the results showed that the DEPs were also related to the development and functions of other systems.
The Serum E 2 Level in Cord Blood and the Effect of E 2 on the Expression of Lumican and Vimentin in HUVECs
According to the protocol of the Iodine [125I] Estradiol Radioimmunoassay Kit (Larewen Biomedical Engineering Technology Co. Ltd.), the serum E 2 levels in cord blood were examined. As shown in Figure 5Aa , the mean serum E 2 level of the IVF group (n ¼ 45) was 21 965.9 6 2063.3 pmol/L (2.20 3 10 À8 M), significantly higher than that of the NC group (10 822.0 6 1333.7 pmol/L [1.08 3 10
À8 M]; n ¼ 48; P , 0.001). We also divided the samples into four subgroups-NC female, IVF female, NC male, and IVF male-and did not detect an association of sex with increased E 2 levels in cord blood (Fig. 5Ab) .
In order to clarify whether high E 2 levels played a role in inducing the alteration of protein expression in the endothelium of blood vessels, we examined the expression levels of lumican and vimentin mRNAs and proteins in HUVECs after treatment with E 2 at different concentrations for 24 h. The results showed that E 2 dose-dependently increased the expression of lumican (Fig. 5, Ba and C) . On the other hand, E 2 at high concentrations (10 À7 M) significantly reduced the expression of vimentin ( 
DISCUSSION
In the present study we found that the IVF children had higher blood pressure than the NC children. After performing iTRAQ and CFS analyses, we identified 47 DEPs in the umbilical veins of IVF newborns, and the bioinformatics analysis showed that the altered proteins were related to cardiovascular development and metabolism. We also found that the serum E 2 level was higher in cord blood from IVF babies. And treatment of HUVECs with high concentrations of E 2 induced the same changes as those in IVF umbilical veins. Our study revealed the alteration of protein expression in umbilical veins from IVF babies and demonstrated that a high concentration of E 2 might be one important factor resulting in these alterations.
Until now there have been several papers showing that offspring resulting from ART, including IVF, had increased risks of suffering systemic and pulmonary vascular dysfunction GAO ET AL.
[11], cardiovascular remodeling [12] , and cardiometabolic disorders [13, 14] . Some studies also revealed that ART children might be taller than NC children, and even the IVFborn children at ages 6-10 yr who were premature and very low birth weight (,1500 g) were significantly taller than NC children [26, 27] . The health risks would be induced by the increased height in the future because evidence has already shown that the rapid growth during early childhood (1-3 yr) in IVF-born children was related to higher blood pressure levels [28] . The present study showed that although the mean blood pressure of IVF children was in a physiological range [29] , it was higher than that of NC children. Because most IVF babies in China were born after the 1990s, we cannot know at the present time whether IVF offspring will have a significantly increased risk of cardiovascular diseases in later life. However, the results from our present study and other studies suggest that IVF offspring might have increased risks of cardiovascular disorders as adults. This needs to be clarified in future studies on adult or elderly IVF offspring.
However, the mechanisms for these disorders remain unclear. In our study, the network analysis of ''developmental disorder, hematological disease, and hereditary disorder'' showed that most proteins in this network were up-regulated in the umbilical veins of IVF-born babies, and these upregulated proteins were mainly related to developmental disorders. The analysis of another network, ''carbohydrate metabolism, small molecule biochemistry, cardiac arrhythmia,'' showed that most proteins were down-regulated in umbilical veins of IVF-born babies, and these down-regulated proteins were mainly related to carbohydrate metabolism. Among these DEPs, three enzymes, including PDHB, GPD1L, and ALDH9A1, were down-regulated. Their decreased expression would lead to a carbon metabolism disorder [30] [31] [32] . The metabolism disorder was related to energy supply, which might also influence vascular development. Our results suggested that the abnormal expression of proteins might be associated with the fast growth and the increased blood pressure in IVF-born children.
Moreover, seven DEPs, including CTSB, DCN, LAMA5, THBS1, TNC, VIM, and TPT1, could be categorized as part of cardiovascular system development, and they had functions in angiogenesis, vasculogenesis, or blood vessel development [33] [34] [35] [36] [37] [38] [39] . On the other hand, in the IVF group, three DEPs, including DCN [40] , TNC [41] , and LUM [42] , which were up-regulated, and other two DEPs, including VIM [43] and TAGLN [44] , which were down-regulated, were structural proteins. Based on the different expression of these structural proteins, we considered that the cells might be subject to structural remodeling, in terms of both the extracellular matrix and the intermediate cytoskeletal filaments. Thus, the altered expression of these proteins might be used to explain the vascular remodeling occurring in IVF offspring [12] . Our data may provide a clue to finding the association of the DEPs with vascular dysfunction in IVF children. However, our results showed that the DEPs were also related to the development and functions of other systems, including tumor morphology, hair and skin development and function, digestive system development and function, etc. Further studies are needed to clarify the association of the DEPs detected in blood vessels with the development and functions of other systems.
To further investigate the causes of DEPs in umbilical veins of IVF newborns, we examined the level of E 2 in cord blood. E 2 is an important sex hormone in the procedure of gestation, which could influence fetal growth [45] . It has been shown that elevated serum E 2 levels could suppress extravillous trophoblast spiral artery invasion, impair blood flow to the placenta, and lead to fetal growth restriction in an animal's first trimester of pregnancy [46] . Our previous study revealed that the serum E 2 levels in the women treated with fresh embryo transfer were significantly higher than those in NC women at 4 and 8 wk of pregnancy [47] . In this study, we for the first time have demonstrated that the level of E 2 in IVF cord blood was still higher than that of the NC group, suggesting that the persistently high concentration of E 2 might be a stimulus influencing cardiovascular system development in fetus and baby. High concentrations of E 2 could induce the same alterations of lumican and vimentin expression in HUVECs, as shown in the proteomic analysis. The results indicated that high E 2 levels might be a factor that resulted in the altered protein expression in the umbilical vein of IVF offspring.
PROTEIN EXPRESSION IN UMBILICAL VEINS OF IVF CHILD
In summary, the present study demonstrated that the expression profile of proteins in the umbilical veins of IVFborn newborns was different from that in NC newborns. The bioinformatics analysis of the 47 DEPs suggested that some DEPs might play important roles in cardiovascular system development and carbohydrate metabolism. High concentrations of E 2 in pregnancy might be a cause of these disorders. Our findings may provide important information for further study of the possible mechanisms underlying cardiovascular remodeling and vascular dysfunction in IVF children, as well as for the evaluation of the risk of cardiovascular abnormality in their postnatal development. However, large-scale analyses will still certainly be required for the safety evaluation of vascular systems in IVF offspring. 
